Tuesday, January 18, 2022

The insightful and incisive young writer Tessa Lena, originally from the USSR, wrote an article and made a video about my situation. Do check out her other projects!

 https://tessa.substack.com/p/dr-meryl-nass

The video was taken off YouTube within 5 minutes (!) and reposted to Rumble.  I appreciated the chance to also talk about other aspects of medical and hospital care today that are extremely troubling.

2 comments:

Winter said...

I am a Mainer and could not believe this is happening, not only in Maine, but in our country. In my latest blog (winterrobinson.com) I wrote that I cannot keep silent about all the questions floating around in my head.

Know that you are not alone.
Winter

Anonymous said...

https://www.theguardian.com/lifeandstyle/2016/jan/27/smartphone-mobile-drug-trials-fda-pfizer-ctti-depression-us-health
2016

In 2007, the FDA established the Clinical Trials Transformation Initiative (CTTI) ...

Dr Martin Landray, professor of medicine and epidemiology at Oxford University and one of the leaders of CTTI’s mobile clinical trial project ...

https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2018/our-innovation/progressing-our-science/transforming-development/index.html#:~:text=Pfizer%20is%20working%20to%20seamlessly,collaborations%20with%20large%20health%20systems.

2018
Pfizer is working to seamlessly integrate clinical trials into the lives of patients through the use of mobile and digital technologies, from electronic consent forms to wearables that enable remote collection of clinical data, as well as collaborations with large health systems. We participate and lead in collaborations such as TransCelerate, the Clinical Trials Transformation Initiative

https://www.bmj.com/content/370/bmj.m2670/rr-1
2020

The story behind the dosage of Hydroxychloroquine used in the RECOVERY trial gets curiouser and curiouser. David Jayne drew attention to the potentially lethal dose of the drug used in the trial.

Martin Landray, has defended the dosage used. He told the BMJ, that the dose was arrived at using “detailed pharmacokinetic models” developed by Nick White and his team ...